ARA-290 (16mg)

ARA-290 (16mg)

This research vial contains ARA-290, a synthetic peptide derived from erythropoietin (EPO), studied for its anti-inflammatory and cytoprotective properties. Researchers have explored ARA-290 for its potential to modulate immune response, promote nerve repair, and reduce tissue damage.

Blend Composition (Per Vial):
ARA-290 – 16mg

Key Characteristics:

• ARA-290: EPO-derived peptide studied for tissue protection and inflammation control

• Investigated for promoting nerve regeneration and reducing oxidative stress

• Sterile vial format ensures consistency in laboratory reconstitution

• Stable peptide composition optimized for reproducible results in cytoprotective research

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.